Announced Wed, 22 Jul · 14:55 IST
Jubilant Ingrevia Q1 FY27 revenue rises 25% YoY to Rs 1,300 cr
Mgmt Guided Margin ImprovementOrder Pipeline DisclosedAnalyst Day Multiyear TargetsInvestor Communications View source PDF
JUBLINGREA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.6%1-day move
₹764.40
prior close
₹732.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+0.8+0.8+2.4-3.6-5.2-2.5-5.1——————
Up moveDown movePending
AI summary
Jubilant Ingrevia reported a strong Q1 FY27. Revenue hit a 15-quarter high of Rs 1,300 cr, up 25% YoY and 10% QoQ. EBITDA grew 37% YoY to Rs 209 cr with margins expanding to 16%. PAT rose 41% YoY to Rs 106 cr, EPS at Rs 6.7. Chemical Intermediates EBITDA surged 240% YoY to Rs 57 cr. CDMO pipeline has 100 plus molecules with Rs 3,500 cr peak potential, 25 plus confirmed. New Multi-Purpose Plant on track for commissioning by end of calendar year 2026.
Likely market impact
Strong beat across segments driven by volume growth and better pricing. Robust CDMO pipeline and capacity addition point to sustained growth momentum ahead.